Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/134382
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Recent developments in relaxin mimetics as therapeutics for cardiovascular diseases |
Author: | Leo, C.H. Jelinic, M. Ng, H.H. Parry, L.J. Tare, M. |
Citation: | Current Opinion in Pharmacology, 2019; 45:42-48 |
Publisher: | Elsevier |
Issue Date: | 2019 |
ISSN: | 1471-4892 1471-4973 |
Statement of Responsibility: | Chen Huei Leo, Maria Jelinic, Hooi Hooi Ng, Laura J Parry, and Marianne Tare |
Abstract: | Cardiovascular disease is the most common cause of mortality worldwide, accounting for almost 50% of all deaths globally. Vascular endothelial dysfunction and fibrosis are critical in the pathophysiology of cardiovascular disease. Relaxin, an insulinlike peptide, is known to have beneficial actions in the cardiovascular system through its vasoprotective and antifibrotic effects. However, relaxin has several limitations of peptide-based drugs such as poor oral bioavailability, laborious, and expensive to synthesize. This review will focus on recent developments in relaxin mimetics, their pharmacology, associated signalling mechanisms, and their therapeutic potential for the management and treatment of cardiovascular disease. |
Keywords: | Animals Humans Cardiovascular Diseases Relaxin Peptide Fragments Biomimetics |
Rights: | © 2019 Elsevier Ltd. All rights reserved. |
DOI: | 10.1016/j.coph.2019.04.001 |
Grant ID: | NHMRC ARC |
Published version: | http://dx.doi.org/10.1016/j.coph.2019.04.001 |
Appears in Collections: | Pharmacology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.